TLR2 and neoplasm: To validate the protection of targeting TLR2 against metastasis and to exclude possible boosting or inhibitory effects of an anti-TLR2 Ab by binding to Fc-receptor non-specifically [19], we investigated if knocking out TLR2/4 affected the metastasis of B16 cells and the tumor cell-induced immunosuppressive microenvironment.